*At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment.
Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.
Why are peptides important?
All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant.
DAXXIFY is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.
Is DAXXIFY well studied?
DAXXIFY was studied in the largest-ever clinical study conducted for a frown line treatment and included more than 2,400 people across different ages and skin types.
• There were no serious treatment-related side effects in clinical trials for DAXXIFYTM
• The active ingredient in DAXXIFYTM is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years
• 96% of people treated with DAXXIFYTM were satisfied with their results†
†96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical